Rebecca M. Burke, Ph.D. - Publications

Affiliations: 
2012 Pharmacology and Experimental Therapeutics Boston University, Boston, MA, United States 
Area:
Neuroscience

2 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Mellott TJ, Pender SM, Burke RM, Langley EA, Blusztajn JK. IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice. Plos One. 9: e94287. PMID 24732467 DOI: 10.1371/Journal.Pone.0094287  0.454
2013 Burke RM, Norman TA, Haydar TF, Slack BE, Leeman SE, Blusztajn JK, Mellott TJ. BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 110: 19567-72. PMID 24218590 DOI: 10.1073/Pnas.1319297110  0.352
Show low-probability matches.